1. Wick MR, Graeme-Cook FM. Pancreatic neuroendocrine neoplasms: a current summary of diagnostic, prognostic, and differential diagnostic information. Am J Clin Pathol. 2001; 115(suppl):S28–S45.
2. Chetty R. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology. Arch Pathol Lab Med. 2008; 132:1285–1289.
Article
3. Eriksson B, Arnberg H, Lindgren PG, et al. Neuroendocrine pancreatic tumors: clinical presentation, biochemical and his-topathological findings in 84 patients. J Intern Med. 1990; 228:103–113.
4. Kauhanen SP, Komar G, Seppä nen MP, et al. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Ann Surg. 2009; 250:957–963.
Article
5. Eriksson B, Ö berg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion. 2000; 62:33–38.
Article
6. Modlin IM, Gustafsson BI, Moss SF, Pavel M, Tsolakis AV, Kidd M. Chromogranin A-biological function and clinical utility in neuro endocrine tumor disease. Ann Surg Oncol. 2010. ;[Epub ahead of print].
Article
7. Simon P, Spilcke-Liss E, Wallaschofski H. Endocrine tumors of the pancreas. Endocrinol Metab Clin North Am. 2006; 35:431–447.
Article
8. Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg. 1994; 178:187–211.
9. Azimuddin K, Chamberlain RS. The surgical management of pancreatic neuroendocrine tumors. Surg Clin North Am. 2001; 81:511–525.
Article
10. Basu B, Sirohi B, Corrie P. Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin. Endocr relat cancer. 2010; 17:R75–R90.
Article